ExxonMobil Investment Management’s Nektar Therapeutics NKTR Stock Holding History

ExxonMobil Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.62M	Buy	+1,642	New	+$2.12M	0.08%	281

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ExxonMobil Investment Management's NKTR Position: Q1 2018 in Review

ExxonMobil Investment Management opened a new position in Nektar Therapeutics (NKTR) in Q1 2018: 1,642 shares worth $2.62M. The stake represents 0.08% of the portfolio and ranks #281 among its holdings.

359 funds tracked by Wall St. Rank hold NKTR as of Q1 2018.

ExxonMobil Investment Management held 1,642 shares of Nektar Therapeutics worth $2.62M as of Q1 2018.
Nektar Therapeutics was a new ExxonMobil Investment Management position in Q1 2018.
Nektar Therapeutics made up 0.08% of ExxonMobil Investment Management's portfolio in Q1 2018, its #281 holding.
359 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2018.

Based on ExxonMobil Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.